当前位置:首页 - 行情中心 - 力诺药包(301188) - 财务分析 - 现金流量表

力诺药包

(301188)

  

流通市值:94.79亿  总市值:94.79亿
流通股本:2.68亿   总股本:2.68亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金511,007,153.84236,615,084.51780,967,572.23575,386,996.23
  收到其他与经营活动有关的现金18,266,956.552,590,500.7964,016,708.5161,013,332.15
  经营活动现金流入小计529,274,110.39239,205,585.3844,984,280.74636,400,328.38
  购买商品、接受劳务支付的现金369,155,175.1181,078,339.92537,254,934.64469,686,626.53
  支付给职工以及为职工支付的现金101,407,675.7947,271,856.91202,769,407.69149,157,162.22
  支付的各项税费22,290,799.237,709,993.7924,931,068.4524,736,423.82
  支付其他与经营活动有关的现金104,715,013.5117,036,146.7599,354,388.0753,292,384.05
  经营活动现金流出小计597,568,663.63253,096,337.37864,309,798.85696,872,596.62
  经营活动产生的现金流量净额-68,294,553.24-13,890,752.07-19,325,518.11-60,472,268.24
二、投资活动产生的现金流量:
  取得投资收益收到的现金213,850.8665,753.432,908,425.132,528,686.24
  处置固定资产、无形资产和其他长期资产收回的现金净额1,173,818.93663,834.929,254,698.58,836,140.8
  收到的其他与投资活动有关的现金157,481,456.0950,000,000851,095,657.39520,643,827.27
  投资活动现金流入小计158,869,125.8850,729,588.35863,258,781.02532,008,654.31
  购建固定资产、无形资产和其他长期资产支付的现金165,271,860.9146,447,534.13287,171,153.78236,274,100.14
  投资支付的现金--84,557,290.5784,000,000
  支付其他与投资活动有关的现金130,480,640.2172,411,971.12619,183,162.61290,341,999.99
  投资活动现金流出小计295,752,501.12118,859,505.25990,911,606.96610,616,100.13
  投资活动产生的现金流量净额-136,883,375.24-68,129,916.9-127,652,825.94-78,607,445.82
三、筹资活动产生的现金流量:
  取得借款收到的现金85,102,853.086,711,045.48265,012,00078,482,000
  收到其他与筹资活动有关的现金9,876,666.67183,208.979,879,333.338,620,350.92
  筹资活动现金流入小计94,979,519.756,894,254.45274,891,333.3387,102,350.92
  偿还债务支付的现金5,211,760.541,650,00015,000,0001,000.55
  分配股利、利润或偿付利息支付的现金29,347,472.461,615,897.4226,841,477.3126,665,263.99
  支付其他与筹资活动有关的现金1,710,014.481,061,760.5483,903,803.6351,677,662.86
  筹资活动现金流出小计36,269,247.484,327,657.96125,745,280.9478,343,927.4
  筹资活动产生的现金流量净额58,710,272.272,566,596.49149,146,052.398,758,423.52
四、汇率变动对现金及现金等价物的影响-3,649,122.35-1,023,545.25-599,088.13-
五、现金及现金等价物净增加额-150,116,778.56-80,477,617.731,568,620.21-130,321,290.54
  加:期初现金及现金等价物余额402,314,997.2402,314,997.2400,746,376.99400,746,376.99
  期末现金及现金等价物余额252,198,218.64321,837,379.47402,314,997.2270,425,086.45
补充资料:
  净利润31,157,397.12-39,660,429.38-
  资产减值准备11,118,363.31-10,300,279.57-
  固定资产和投资性房地产折旧66,290,996.9-124,622,050.58-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧66,290,996.9-124,622,050.58-
  无形资产摊销1,537,712.08-2,236,488.58-
  长期待摊费用摊销952,429.64-2,936,187.74-
  处置固定资产、无形资产和其他长期资产的损失-4,324,467.43--2,402,286.5-
  固定资产报废损失-63,187.66-7,538.32-
  公允价值变动损失-481,703.83--1,666,557.35-
  财务费用10,551,028.46-26,518,197.36-
  投资损失-3,569,422.99--10,861,449.23-
  递延所得税-23,269,986.38--6,764,756.33-
  其中:递延所得税资产减少-20,144,806.43-6,299,733.76-
    递延所得税负债增加-3,125,179.95--13,064,490.09-
  存货的减少-63,899,980.59--193,287,792.33-
  经营性应收项目的减少-146,278,416.78--195,332,246.47-
  经营性应付项目的增加32,907,005.89-184,708,398.57-
  其他17,390,867.08---
  现金的期末余额252,198,218.64-402,314,997.2-
  减:现金的期初余额402,314,997.2-400,746,376.99-
  现金及现金等价物的净增加额-150,116,778.56-1,568,620.21-
公告日期2026-08-252026-04-232026-04-232025-10-28
审计意见(境内)标准无保留意见
TOP↑